hydroxychloroquine has been researched along with Deafness in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sensorineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA." | 5.31 | Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. ( Borman, P; Bostan, EE; Ikinciogullari, A; Ozoran, K; Seçkin, U, 2000) |
| "Sensorineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA." | 1.31 | Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. ( Borman, P; Bostan, EE; Ikinciogullari, A; Ozoran, K; Seçkin, U, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seçkin, U | 1 |
| Ozoran, K | 1 |
| Ikinciogullari, A | 1 |
| Borman, P | 1 |
| Bostan, EE | 1 |
1 other study available for hydroxychloroquine and Deafness
| Article | Year |
|---|---|
Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Deafness; Female; Humans; Hydroxychloroquine | 2000 |